Exact Mass: 394.0084
Exact Mass Matches: 394.0084
Found 109 metabolites which its exact mass value is equals to given mass value 394.0084,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Alilusem
({[7-chloro-1-(2-methylbenzoyl)-1,2,3,4-tetrahydroquinolin-4-ylidene]amino}oxy)sulfonic acid
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
NCGC00380829-01!1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
Uracil octosyl acid 5-phosphate
Uracil octosyl acid 5-phosphate
An N-glycosyl compound with formula C12H15N2O11P that is a common intermediate in the biosynthesis of nikkomycins and polyoxins by bacteria.
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2,3-dideoxy-alpha-D-ribofuranos-5-yl group.
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
3-(enolpyruvyl)uridine 5-monophosphate
3-(enolpyruvyl)uridine 5-monophosphate
A uridine 5-phosphate that is UMP in which the hydroxy hydrogen at position 3 has been replaced by an enolpyruvyl group.
M1002
M1002
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(5s)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(5s)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
5-(10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl)oxolan-2-one
5-(10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl)oxolan-2-one
(2e,4e,7s)-8,8,8-trichloro-7-methyl-n-[(1r)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(2e,4e,7s)-8,8,8-trichloro-7-methyl-n-[(1r)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(5r)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(5r)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
2-(3-chloro-2,5-dihydroxyphenyl)-5-hydroxy-3,7,8-trimethoxychromen-4-one
2-(3-chloro-2,5-dihydroxyphenyl)-5-hydroxy-3,7,8-trimethoxychromen-4-one
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
(5r)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(5r)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(5s)-5-[(1e,3r)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
(5s)-5-[(1e,3r)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
methyl 5-bromo-10-hydroxy-8-methyl-3,11-dioxo-1h-oxepino[4,3-b]chromene-1-carboxylate
methyl 5-bromo-10-hydroxy-8-methyl-3,11-dioxo-1h-oxepino[4,3-b]chromene-1-carboxylate
4-[2-(5-bromo-2-oxo-1h-indol-3-ylidene)hydrazin-1-yl]benzenesulfonamide
4-[2-(5-bromo-2-oxo-1h-indol-3-ylidene)hydrazin-1-yl]benzenesulfonamide
2-[3-chloro-2-hydroxy-4-methoxy-6-(methoxycarbonyl)benzoyl]-6-hydroxy-4-methylbenzoic acid
2-[3-chloro-2-hydroxy-4-methoxy-6-(methoxycarbonyl)benzoyl]-6-hydroxy-4-methylbenzoic acid
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
(5s)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
(5s)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
(2e,4e)-8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(2e,4e)-8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5r)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
(5r)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(5r,6r)-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5r,6r)-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5s)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
(5s)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
5-(10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl)oxolan-2-one
5-(10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl)oxolan-2-one
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
